Literatur
- 1
Stange E F, Schreiber S, Folsch U R. et al .
Diagnostik und Therapie des Morbus Crohn - Ergebnisse einer Evidenz-basierten Konsensuskonferenz
der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen.
Z Gastroenterol.
2003;
41
19-20
- 2
Hoffmann J, Zeitz M.
[Chronically active Crohn’s disease].
Z Gastroenterol.
2003;
41
31-35
- 3
Ramsey-Goldman R, Mientus J M, Kutzer J E. et al .
Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive
drugs.
J Rheumatol.
1993;
20
1152-1157
- 4
Rajapakse R O, Korelitz B I, Zlatanic J. et al .
Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory
bowel disease.
Am J Gastroenterol.
2000;
95
684-688
- 5
Alstead E M, Ritchie J K, Lennard-Jones J E. et al .
Safety of azathioprine in pregnancy in inflammatory bowel disease.
Gastroenterology.
1990;
99
443-446
- 6
Francella A, Dyan A, Bodian C. et al .
The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease:
a retrospective cohort study.
Gastroenterology.
2003;
124
9-17
- 7
Connell W R.
Safety of drug therapy for inflammatory bowel disease in pregnant and nursing women.
Inflammatory Bowel Diseases.
1996;
2
33-47
- 8
Mate-Jimenez J, Hermida C, Cantero-Perona J. et al .
6-mercaptopurine or methotrexate added to prednisone induces and maintains remission
in steroid-dependent inflammatory bowel disease.
Eur J Gastroenterol Hepatol.
2000;
12
1227-1233
PD Dr. Max Reinshagen
Medizinische Klinik l, Städtisches Klinikum Braunschweig
Salzdahlumer Straße 90
38126 Braunschweig
Telefon: 05 31/5 95 24 30
Fax: 05 31/59 52 65
eMail: m.reinshagen@klinikum-braunschweig.de
PD Dr. Jörg C. Hoffmann
Prof. Dr. Martin Zeitz
Medizinische Klinik I, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin
Hindenburgdamm 30
12200 Berlin
eMail: joerg.hoffmann@charite.de;martin.zeitz@charite.de
